News
Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a ...
Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American ...
2h
News-Medical.Net on MSNCurcumin shows promise for treating obesity, inflammation, and neurodegenerative diseasesResearchers explore the medicinal role of curcumin in the treatment and prevention of neuroinflammation and metabolic ...
15h
News-Medical.Net on MSNTailored treatment guided by dual biopsy approach may improve outcomes for patients with advanced cancersPatients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...
Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...
The potential of big data analytics (BDA) to transform the prevention, diagnosis, and treatment of cardiovascular diseases ...
8h
Health and Me on MSNFDA Greenlights Zevaskyn for Rare Genetic Skin ConditionWith FDA approval, Zevaskyn is set to be a game-changer in the treatment of recessive dystrophic epidermolysis ...
Q1 2025 Earnings Conference Call April 29, 2025 8:00 AM ETCompany ParticipantsSloan Simpson - Head of Investor ...
FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come.
AUA annual meeting featured the IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder cancer, moderated by Dr. Peter Black, with a debate between Drs. Wes Kassouf and ...
A new study led by a pair of researchers at the University of Massachusetts Amherst turns long-held conventional wisdom about a certain type of polymer on its head, greatly expanding understanding of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results